US Patent Issued to National University of Singapore on Sept. 2 for "Methods for enhancing efficacy of therapeutic immune cells" (Singaporean Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,492, issued on Sept. 2, was assigned to National University of Singapore (Singapore).

"Methods for enhancing efficacy of therapeutic immune cells" was invented by Dario Campana (Singapore) and Takahiro Kamiya (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of using a receptor (e.g., chimeric antigen receptor-CAR) that activates an immune response upon binding a cancer cell ligand in conjunction with a target-binding molecule that targets a protein or molecule for removal or neutralization to generate enhanced anti-cancer immune cells. The present invention also relates to engineered immune cells ha...